Selected research
Industry Research
Blood Banking and Blood Products Industry Research Report 2026
Market perspective
The global Blood Banking and Blood Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Blood Banking and Blood Products market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Blood Banking and Blood Products market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Blood Banking and Blood Products market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Blood Banking and Blood Products include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Blood Banking and Blood Products market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Blood Banking and Blood Products.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blood Banking and Blood Products Market by Company
Red Cross Society of China
Yuanda Shuyang
Weiguang Bio
Tiantan Bio
CBPO
Shuanglin Bio
RAAS
Nanyue Bio
Hualan Bio
Boya Bio
Vitalant
Takeda
Sanquin Blood Supply Foundation
Octapharma
NHS Blood and Transplant
New York Blood Center
National Blood Transfusion Council
LFB Group
KM Biologics
Kedrion
Japan Red Cross Society
Grifols
CSL
Canadian Blood Services
BPL
Blood Bank of Alaska
Biotest
Australia Red Cross
American Red Cross
America’s Blood Centers
Blood Banking and Blood Products Segment by Type
RBCs
Whole Blood
Plasma
Plasma Fractionation Products
Plts
Blood Banking and Blood Products Segment by Application
Clinic
Hospital
Retail Pharmacy
Others
Blood Banking and Blood Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Blood Banking and Blood Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Blood Banking and Blood Products Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Blood Banking and Blood Products Revenue Market Share by Type (2021-2026)
Table 7. Global Blood Banking and Blood Products Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Blood Banking and Blood Products Revenue Market Share by Type (2027-2032)
Table 9. Global Blood Banking and Blood Products Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Blood Banking and Blood Products Revenue Market Share by Application (2021-2026)
Table 11. Global Blood Banking and Blood Products Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Blood Banking and Blood Products Revenue Market Share by Application (2027-2032)
Table 13. Global Blood Banking and Blood Products Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Blood Banking and Blood Products Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Blood Banking and Blood Products Market Share by Region (2021-2026)
Table 16. Global Blood Banking and Blood Products Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Blood Banking and Blood Products Market Share by Region (2027-2032)
Table 18. Blood Banking and Blood Products Industry Trends
Table 19. Blood Banking and Blood Products Industry Drivers
Table 20. Blood Banking and Blood Products Industry Opportunities and Challenges
Table 21. Blood Banking and Blood Products Market Restraints
Table 22. Global Top Blood Banking and Blood Products Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Blood Banking and Blood Products Revenue Market Share by Players (2021-2026)
Table 24. Global Blood Banking and Blood Products Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Blood Banking and Blood Products, Headquarters and Area Served
Table 26. Global Blood Banking and Blood Products Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Blood Banking and Blood Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Blood Banking and Blood Products Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Blood Banking and Blood Products Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Blood Banking and Blood Products Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Blood Banking and Blood Products Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Blood Banking and Blood Products Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Blood Banking and Blood Products Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Blood Banking and Blood Products Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Blood Banking and Blood Products Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Blood Banking and Blood Products Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Blood Banking and Blood Products Market Size by Country (2027-2032) & (US$ Million)
Table 45. Red Cross Society of China Company Information
Table 46. Red Cross Society of China Business Overview
Table 47. Red Cross Society of China Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 48. Red Cross Society of China Blood Banking and Blood Products Product Portfolio
Table 49. Red Cross Society of China Recent Developments
Table 50. Yuanda Shuyang Company Information
Table 51. Yuanda Shuyang Business Overview
Table 52. Yuanda Shuyang Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 53. Yuanda Shuyang Blood Banking and Blood Products Product Portfolio
Table 54. Yuanda Shuyang Recent Developments
Table 55. Weiguang Bio Company Information
Table 56. Weiguang Bio Business Overview
Table 57. Weiguang Bio Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 58. Weiguang Bio Blood Banking and Blood Products Product Portfolio
Table 59. Weiguang Bio Recent Developments
Table 60. Tiantan Bio Company Information
Table 61. Tiantan Bio Business Overview
Table 62. Tiantan Bio Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 63. Tiantan Bio Blood Banking and Blood Products Product Portfolio
Table 64. Tiantan Bio Recent Developments
Table 65. CBPO Company Information
Table 66. CBPO Business Overview
Table 67. CBPO Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 68. CBPO Blood Banking and Blood Products Product Portfolio
Table 69. CBPO Recent Developments
Table 70. Shuanglin Bio Company Information
Table 71. Shuanglin Bio Business Overview
Table 72. Shuanglin Bio Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 73. Shuanglin Bio Blood Banking and Blood Products Product Portfolio
Table 74. Shuanglin Bio Recent Developments
Table 75. RAAS Company Information
Table 76. RAAS Business Overview
Table 77. RAAS Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 78. RAAS Blood Banking and Blood Products Product Portfolio
Table 79. RAAS Recent Developments
Table 80. Nanyue Bio Company Information
Table 81. Nanyue Bio Business Overview
Table 82. Nanyue Bio Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 83. Nanyue Bio Blood Banking and Blood Products Product Portfolio
Table 84. Nanyue Bio Recent Developments
Table 85. Hualan Bio Company Information
Table 86. Hualan Bio Business Overview
Table 87. Hualan Bio Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 88. Hualan Bio Blood Banking and Blood Products Product Portfolio
Table 89. Hualan Bio Recent Developments
Table 90. Boya Bio Company Information
Table 91. Boya Bio Business Overview
Table 92. Boya Bio Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 93. Boya Bio Blood Banking and Blood Products Product Portfolio
Table 94. Boya Bio Recent Developments
Table 95. Vitalant Company Information
Table 96. Vitalant Business Overview
Table 97. Vitalant Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 98. Vitalant Blood Banking and Blood Products Product Portfolio
Table 99. Vitalant Recent Developments
Table 100. Takeda Company Information
Table 101. Takeda Business Overview
Table 102. Takeda Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 103. Takeda Blood Banking and Blood Products Product Portfolio
Table 104. Takeda Recent Developments
Table 105. Sanquin Blood Supply Foundation Company Information
Table 106. Sanquin Blood Supply Foundation Business Overview
Table 107. Sanquin Blood Supply Foundation Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 108. Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
Table 109. Sanquin Blood Supply Foundation Recent Developments
Table 110. Octapharma Company Information
Table 111. Octapharma Business Overview
Table 112. Octapharma Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 113. Octapharma Blood Banking and Blood Products Product Portfolio
Table 114. Octapharma Recent Developments
Table 115. NHS Blood and Transplant Company Information
Table 116. NHS Blood and Transplant Business Overview
Table 117. NHS Blood and Transplant Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 118. NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
Table 119. NHS Blood and Transplant Recent Developments
Table 120. New York Blood Center Company Information
Table 121. New York Blood Center Business Overview
Table 122. New York Blood Center Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 123. New York Blood Center Blood Banking and Blood Products Product Portfolio
Table 124. New York Blood Center Recent Developments
Table 125. National Blood Transfusion Council Company Information
Table 126. National Blood Transfusion Council Business Overview
Table 127. National Blood Transfusion Council Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 128. National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio
Table 129. National Blood Transfusion Council Recent Developments
Table 130. LFB Group Company Information
Table 131. LFB Group Business Overview
Table 132. LFB Group Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 133. LFB Group Blood Banking and Blood Products Product Portfolio
Table 134. LFB Group Recent Developments
Table 135. KM Biologics Company Information
Table 136. KM Biologics Business Overview
Table 137. KM Biologics Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 138. KM Biologics Blood Banking and Blood Products Product Portfolio
Table 139. KM Biologics Recent Developments
Table 140. Kedrion Company Information
Table 141. Kedrion Business Overview
Table 142. Kedrion Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 143. Kedrion Blood Banking and Blood Products Product Portfolio
Table 144. Kedrion Recent Developments
Table 145. Japan Red Cross Society Company Information
Table 146. Japan Red Cross Society Business Overview
Table 147. Japan Red Cross Society Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 148. Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
Table 149. Japan Red Cross Society Recent Developments
Table 150. Grifols Company Information
Table 151. Grifols Business Overview
Table 152. Grifols Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 153. Grifols Blood Banking and Blood Products Product Portfolio
Table 154. Grifols Recent Developments
Table 155. CSL Company Information
Table 156. CSL Business Overview
Table 157. CSL Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 158. CSL Blood Banking and Blood Products Product Portfolio
Table 159. CSL Recent Developments
Table 160. Canadian Blood Services Company Information
Table 161. Canadian Blood Services Business Overview
Table 162. Canadian Blood Services Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 163. Canadian Blood Services Blood Banking and Blood Products Product Portfolio
Table 164. Canadian Blood Services Recent Developments
Table 165. BPL Company Information
Table 166. BPL Business Overview
Table 167. BPL Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 168. BPL Blood Banking and Blood Products Product Portfolio
Table 169. BPL Recent Developments
Table 170. Blood Bank of Alaska Company Information
Table 171. Blood Bank of Alaska Business Overview
Table 172. Blood Bank of Alaska Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 173. Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio
Table 174. Blood Bank of Alaska Recent Developments
Table 175. Biotest Company Information
Table 176. Biotest Business Overview
Table 177. Biotest Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 178. Biotest Blood Banking and Blood Products Product Portfolio
Table 179. Biotest Recent Developments
Table 180. Australia Red Cross Company Information
Table 181. Australia Red Cross Business Overview
Table 182. Australia Red Cross Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 183. Australia Red Cross Blood Banking and Blood Products Product Portfolio
Table 184. Australia Red Cross Recent Developments
Table 185. American Red Cross Company Information
Table 186. American Red Cross Business Overview
Table 187. American Red Cross Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 188. American Red Cross Blood Banking and Blood Products Product Portfolio
Table 189. American Red Cross Recent Developments
Table 190. America’s Blood Centers Company Information
Table 191. America’s Blood Centers Business Overview
Table 192. America’s Blood Centers Revenue in Blood Banking and Blood Products Business (2021-2026) & (US$ Million)
Table 193. America’s Blood Centers Blood Banking and Blood Products Product Portfolio
Table 194. America’s Blood Centers Recent Developments
Table 195. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Blood Banking and Blood Products Product Image
Figure 5. Global Blood Banking and Blood Products Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Blood Banking and Blood Products Market Share by Type: 2025 VS 2032
Figure 7. RBCs Product
Figure 8. Whole Blood Product
Figure 9. Plasma Product
Figure 10. Plasma Fractionation Products Product
Figure 11. Plts Product
Figure 12. Global Blood Banking and Blood Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Blood Banking and Blood Products Market Share by Application: 2025 VS 2032
Figure 14. Clinic Product
Figure 15. Hospital Product
Figure 16. Retail Pharmacy Product
Figure 17. Others Product
Figure 18. Global Blood Banking and Blood Products Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 19. Global Blood Banking and Blood Products Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 20. Global Blood Banking and Blood Products Market Share by Region: 2025 VS 2032
Figure 21. Global Blood Banking and Blood Products Market Share by Players in 2025
Figure 22. Global Blood Banking and Blood Products Manufacturers Established Date
Figure 23. Global Top 5 and 10 Blood Banking and Blood Products Players Market Share by Revenue in 2025
Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 25. North America Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. North America Blood Banking and Blood Products Market Share by Country (2021-2032)
Figure 27. United States Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Canada Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Mexico Blood Banking and Blood Products Market Share by Country (2021-2032)
Figure 30. Europe Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Europe Blood Banking and Blood Products Market Share by Country (2021-2032)
Figure 32. Germany Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. France Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. U.K. Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Italy Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Spain Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Russia Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Netherlands Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Nordic Countries Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Asia-Pacific Blood Banking and Blood Products Market Share by Country (2021-2032)
Figure 42. China Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. Japan Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. South Korea Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. India Blood Banking and Blood Products Market Share by Country (2021-2032)
Figure 47. Australia Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. China Taiwan Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. South America Blood Banking and Blood Products Market Share by Country (2021-2032)
Figure 52. Brazil Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Argentina Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Chile Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Colombia Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Peru Blood Banking and Blood Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 57. Red Cross Society of China Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 58. Yuanda Shuyang Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 59. Weiguang Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 60. Tiantan Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 61. CBPO Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 62. Shuanglin Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 63. RAAS Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 64. Nanyue Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 65. Hualan Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 66. Boya Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 67. Vitalant Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 68. Takeda Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 69. Sanquin Blood Supply Foundation Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 70. Octapharma Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 71. NHS Blood and Transplant Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 72. New York Blood Center Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 73. National Blood Transfusion Council Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 74. LFB Group Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 75. KM Biologics Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 76. Kedrion Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 77. Japan Red Cross Society Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 78. Grifols Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 79. CSL Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 80. Canadian Blood Services Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 81. BPL Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 82. Blood Bank of Alaska Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 83. Biotest Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 84. Australia Red Cross Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 85. American Red Cross Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Figure 86. America’s Blood Centers Revenue Growth Rate in Blood Banking and Blood Products Business (2021-2026)
Scope & coverage.
Types
- RBCs
- Whole Blood
- Plasma
- Plasma Fractionation Products
- Plts
Applications
- Clinic
- Hospital
- Retail Pharmacy
- Others
Companies covered
- Red Cross Society of China
- Yuanda Shuyang
- Weiguang Bio
- Tiantan Bio
- CBPO
- Shuanglin Bio
- RAAS
- Nanyue Bio
- Hualan Bio
- Boya Bio
- Vitalant
- Takeda
- Sanquin Blood Supply Foundation
- Octapharma
- NHS Blood and Transplant
- New York Blood Center
- National Blood Transfusion Council
- LFB Group
- KM Biologics
- Kedrion
- Japan Red Cross Society
- Grifols
- CSL
- Canadian Blood Services
- BPL
- Blood Bank of Alaska
- Biotest
- Australia Red Cross
- American Red Cross
- America’s Blood Centers
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Blood Banking and Blood Products by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 RBCs
- 2.2.3 Whole Blood
- 2.2.4 Plasma
- 2.2.5 Plasma Fractionation Products
- 2.2.6 Plts
- 2.3 Blood Banking and Blood Products by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinic
- 2.3.3 Hospital
- 2.3.4 Retail Pharmacy
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Blood Banking and Blood Products Breakdown Data by Type
- 3.1 Global Blood Banking and Blood Products Historic Market Size by Type (2021-2026)
- 3.2 Global Blood Banking and Blood Products Forecasted Market Size by Type (2027-2032)
4 Blood Banking and Blood Products Breakdown Data by Application
- 4.1 Global Blood Banking and Blood Products Historic Market Size by Application (2021-2026)
- 4.2 Global Blood Banking and Blood Products Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Blood Banking and Blood Products Market Perspective (2021-2032)
- 5.2 Global Blood Banking and Blood Products Growth Trends by Region
- 5.2.1 Global Blood Banking and Blood Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Blood Banking and Blood Products Historic Market Size by Region (2021-2026)
- 5.2.3 Blood Banking and Blood Products Forecasted Market Size by Region (2027-2032)
- 5.3 Blood Banking and Blood Products Market Dynamics
- 5.3.1 Blood Banking and Blood Products Industry Trends
- 5.3.2 Blood Banking and Blood Products Market Drivers
- 5.3.3 Blood Banking and Blood Products Market Challenges
- 5.3.4 Blood Banking and Blood Products Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Blood Banking and Blood Products Players by Revenue
- 6.1.1 Global Top Blood Banking and Blood Products Players by Revenue (2021-2026)
- 6.1.2 Global Blood Banking and Blood Products Revenue Market Share by Players (2021-2026)
- 6.2 Global Blood Banking and Blood Products Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Blood Banking and Blood Products Head Office and Area Served
- 6.4 Global Blood Banking and Blood Products Players, Product Type & Application
- 6.5 Global Blood Banking and Blood Products Manufacturers Established Date
- 6.6 Global Blood Banking and Blood Products Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Blood Banking and Blood Products Market Size (2021-2032)
- 7.2 North America Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Blood Banking and Blood Products Market Size by Country (2021-2026)
- 7.4 North America Blood Banking and Blood Products Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Blood Banking and Blood Products Market Size (2021-2032)
- 8.2 Europe Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Blood Banking and Blood Products Market Size by Country (2021-2026)
- 8.4 Europe Blood Banking and Blood Products Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Blood Banking and Blood Products Market Size (2021-2032)
- 9.2 Asia-Pacific Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Blood Banking and Blood Products Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Blood Banking and Blood Products Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Blood Banking and Blood Products Market Size (2021-2032)
- 10.2 South America Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Blood Banking and Blood Products Market Size by Country (2021-2026)
- 10.4 South America Blood Banking and Blood Products Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Blood Banking and Blood Products Market Size (2021-2032)
- 11.2 Middle East & Africa Blood Banking and Blood Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Blood Banking and Blood Products Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Blood Banking and Blood Products Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Red Cross Society of China
- 12.1.1 Red Cross Society of China Company Information
- 12.1.2 Red Cross Society of China Business Overview
- 12.1.3 Red Cross Society of China Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.1.4 Red Cross Society of China Blood Banking and Blood Products Product Portfolio
- 12.1.5 Red Cross Society of China Recent Developments
- 12.2 Yuanda Shuyang
- 12.2.1 Yuanda Shuyang Company Information
- 12.2.2 Yuanda Shuyang Business Overview
- 12.2.3 Yuanda Shuyang Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.2.4 Yuanda Shuyang Blood Banking and Blood Products Product Portfolio
- 12.2.5 Yuanda Shuyang Recent Developments
- 12.3 Weiguang Bio
- 12.3.1 Weiguang Bio Company Information
- 12.3.2 Weiguang Bio Business Overview
- 12.3.3 Weiguang Bio Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.3.4 Weiguang Bio Blood Banking and Blood Products Product Portfolio
- 12.3.5 Weiguang Bio Recent Developments
- 12.4 Tiantan Bio
- 12.4.1 Tiantan Bio Company Information
- 12.4.2 Tiantan Bio Business Overview
- 12.4.3 Tiantan Bio Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.4.4 Tiantan Bio Blood Banking and Blood Products Product Portfolio
- 12.4.5 Tiantan Bio Recent Developments
- 12.5 CBPO
- 12.5.1 CBPO Company Information
- 12.5.2 CBPO Business Overview
- 12.5.3 CBPO Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.5.4 CBPO Blood Banking and Blood Products Product Portfolio
- 12.5.5 CBPO Recent Developments
- 12.6 Shuanglin Bio
- 12.6.1 Shuanglin Bio Company Information
- 12.6.2 Shuanglin Bio Business Overview
- 12.6.3 Shuanglin Bio Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.6.4 Shuanglin Bio Blood Banking and Blood Products Product Portfolio
- 12.6.5 Shuanglin Bio Recent Developments
- 12.7 RAAS
- 12.7.1 RAAS Company Information
- 12.7.2 RAAS Business Overview
- 12.7.3 RAAS Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.7.4 RAAS Blood Banking and Blood Products Product Portfolio
- 12.7.5 RAAS Recent Developments
- 12.8 Nanyue Bio
- 12.8.1 Nanyue Bio Company Information
- 12.8.2 Nanyue Bio Business Overview
- 12.8.3 Nanyue Bio Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.8.4 Nanyue Bio Blood Banking and Blood Products Product Portfolio
- 12.8.5 Nanyue Bio Recent Developments
- 12.9 Hualan Bio
- 12.9.1 Hualan Bio Company Information
- 12.9.2 Hualan Bio Business Overview
- 12.9.3 Hualan Bio Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.9.4 Hualan Bio Blood Banking and Blood Products Product Portfolio
- 12.9.5 Hualan Bio Recent Developments
- 12.10 Boya Bio
- 12.10.1 Boya Bio Company Information
- 12.10.2 Boya Bio Business Overview
- 12.10.3 Boya Bio Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.10.4 Boya Bio Blood Banking and Blood Products Product Portfolio
- 12.10.5 Boya Bio Recent Developments
- 12.11 Vitalant
- 12.11.1 Vitalant Company Information
- 12.11.2 Vitalant Business Overview
- 12.11.3 Vitalant Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.11.4 Vitalant Blood Banking and Blood Products Product Portfolio
- 12.11.5 Vitalant Recent Developments
- 12.12 Takeda
- 12.12.1 Takeda Company Information
- 12.12.2 Takeda Business Overview
- 12.12.3 Takeda Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.12.4 Takeda Blood Banking and Blood Products Product Portfolio
- 12.12.5 Takeda Recent Developments
- 12.13 Sanquin Blood Supply Foundation
- 12.13.1 Sanquin Blood Supply Foundation Company Information
- 12.13.2 Sanquin Blood Supply Foundation Business Overview
- 12.13.3 Sanquin Blood Supply Foundation Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.13.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
- 12.13.5 Sanquin Blood Supply Foundation Recent Developments
- 12.14 Octapharma
- 12.14.1 Octapharma Company Information
- 12.14.2 Octapharma Business Overview
- 12.14.3 Octapharma Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.14.4 Octapharma Blood Banking and Blood Products Product Portfolio
- 12.14.5 Octapharma Recent Developments
- 12.15 NHS Blood and Transplant
- 12.15.1 NHS Blood and Transplant Company Information
- 12.15.2 NHS Blood and Transplant Business Overview
- 12.15.3 NHS Blood and Transplant Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.15.4 NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
- 12.15.5 NHS Blood and Transplant Recent Developments
- 12.16 New York Blood Center
- 12.16.1 New York Blood Center Company Information
- 12.16.2 New York Blood Center Business Overview
- 12.16.3 New York Blood Center Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.16.4 New York Blood Center Blood Banking and Blood Products Product Portfolio
- 12.16.5 New York Blood Center Recent Developments
- 12.17 National Blood Transfusion Council
- 12.17.1 National Blood Transfusion Council Company Information
- 12.17.2 National Blood Transfusion Council Business Overview
- 12.17.3 National Blood Transfusion Council Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.17.4 National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio
- 12.17.5 National Blood Transfusion Council Recent Developments
- 12.18 LFB Group
- 12.18.1 LFB Group Company Information
- 12.18.2 LFB Group Business Overview
- 12.18.3 LFB Group Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.18.4 LFB Group Blood Banking and Blood Products Product Portfolio
- 12.18.5 LFB Group Recent Developments
- 12.19 KM Biologics
- 12.19.1 KM Biologics Company Information
- 12.19.2 KM Biologics Business Overview
- 12.19.3 KM Biologics Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.19.4 KM Biologics Blood Banking and Blood Products Product Portfolio
- 12.19.5 KM Biologics Recent Developments
- 12.20 Kedrion
- 12.20.1 Kedrion Company Information
- 12.20.2 Kedrion Business Overview
- 12.20.3 Kedrion Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.20.4 Kedrion Blood Banking and Blood Products Product Portfolio
- 12.20.5 Kedrion Recent Developments
- 12.21 Japan Red Cross Society
- 12.21.1 Japan Red Cross Society Company Information
- 12.21.2 Japan Red Cross Society Business Overview
- 12.21.3 Japan Red Cross Society Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.21.4 Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
- 12.21.5 Japan Red Cross Society Recent Developments
- 12.22 Grifols
- 12.22.1 Grifols Company Information
- 12.22.2 Grifols Business Overview
- 12.22.3 Grifols Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.22.4 Grifols Blood Banking and Blood Products Product Portfolio
- 12.22.5 Grifols Recent Developments
- 12.23 CSL
- 12.23.1 CSL Company Information
- 12.23.2 CSL Business Overview
- 12.23.3 CSL Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.23.4 CSL Blood Banking and Blood Products Product Portfolio
- 12.23.5 CSL Recent Developments
- 12.24 Canadian Blood Services
- 12.24.1 Canadian Blood Services Company Information
- 12.24.2 Canadian Blood Services Business Overview
- 12.24.3 Canadian Blood Services Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.24.4 Canadian Blood Services Blood Banking and Blood Products Product Portfolio
- 12.24.5 Canadian Blood Services Recent Developments
- 12.25 BPL
- 12.25.1 BPL Company Information
- 12.25.2 BPL Business Overview
- 12.25.3 BPL Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.25.4 BPL Blood Banking and Blood Products Product Portfolio
- 12.25.5 BPL Recent Developments
- 12.26 Blood Bank of Alaska
- 12.26.1 Blood Bank of Alaska Company Information
- 12.26.2 Blood Bank of Alaska Business Overview
- 12.26.3 Blood Bank of Alaska Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.26.4 Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio
- 12.26.5 Blood Bank of Alaska Recent Developments
- 12.27 Biotest
- 12.27.1 Biotest Company Information
- 12.27.2 Biotest Business Overview
- 12.27.3 Biotest Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.27.4 Biotest Blood Banking and Blood Products Product Portfolio
- 12.27.5 Biotest Recent Developments
- 12.28 Australia Red Cross
- 12.28.1 Australia Red Cross Company Information
- 12.28.2 Australia Red Cross Business Overview
- 12.28.3 Australia Red Cross Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.28.4 Australia Red Cross Blood Banking and Blood Products Product Portfolio
- 12.28.5 Australia Red Cross Recent Developments
- 12.29 American Red Cross
- 12.29.1 American Red Cross Company Information
- 12.29.2 American Red Cross Business Overview
- 12.29.3 American Red Cross Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.29.4 American Red Cross Blood Banking and Blood Products Product Portfolio
- 12.29.5 American Red Cross Recent Developments
- 12.30 America’s Blood Centers
- 12.30.1 America’s Blood Centers Company Information
- 12.30.2 America’s Blood Centers Business Overview
- 12.30.3 America’s Blood Centers Revenue in Blood Banking and Blood Products Business (2021-2026)
- 12.30.4 America’s Blood Centers Blood Banking and Blood Products Product Portfolio
- 12.30.5 America’s Blood Centers Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst